ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag salary industry biotech workplace

2016 Life Sciences Salary Survey
Karen Zusi | Nov 1, 2016 | 10+ min read
Most researchers feel stimulated by their work but are dissatisfied with their compensation, according to this year’s results.
Women looks at computer screen in a lab coat and mask
Quest for Research Freedom Fuels African Biotech Boom
Linda Nordling | Jul 1, 2021 | 6 min read
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Best Places to Work Industry, 2011
Hannah Waters | May 1, 2011 | 9 min read
By forging new relationships and finding novel uses for existing technologies, this year’s top companies are employing creative ways to advance their science.
Biotech Mergers Risky For Bench Scientists
Susan L-J Dickinson | Oct 27, 1991 | 10 min read
Today's trend toward industry consolidation yields a grim byproduct for some researchers: the loss of their jobs Chiron buys Cetus, while Genzyme merges with Integrated Genetics. Quidel acquires Monoclonal Antibodies, and American Home Products agrees to buy 60 percent of Genetics Institute. The headlines are coming fast and furious these days. But while the torrent of announcements concerning mergers and acquisitions among biotechnology firms are greeted warmly by many industry watchers as a
Forging Alliances with Industry
A. J. S. Rayl | Apr 2, 2000 | 6 min read
Virtually all of the professional master's degree (PMD) programs have consulted with industry along the way, and each academic institution maintains strong communication through retreats, conferences, and meetings. "We've been involving industry pretty heavily, not so much in developing curricula--we're doing that ourselves--but certainly in getting feedback from them on industry trends and jobs, and lining them up for internships for our students," says Keck Graduate Institute's David Gal
Start It Up
Dan Cossins | Apr 1, 2013 | 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
Best Places to Work 2006: Industry
Karen Pallarito | Apr 1, 2006 | 7 min read
FEATUREBest Places to Work 2006: Industry   Courtesy of Transform PharmaceuticalsWhat makes a company a great place to work? In our fourth annual survey, industry scientists share their insights.BY KAREN PALLARITOBrian Hopkins, a PhD research scientist and project leader at Infinity Pharmaceuticals, joined the Cambridge, Mass., company in May 2002 partly because he liked its DOS (diversity-oriented synthesis
Biotech Firm Learns Hard Lessons As Its Founder Seeks To Halt Slide
Sally Lehrman | Jun 24, 1990 | 8 min read
Applied Biosystems finds that as a start-up's glamour fades, it must stress a return to basics FOSTER CITY, CALIF. - The engineer who cofounded Applied Biosystems and made it into a superstar of the biotech instruments industry, only to step back and see it stumble, is back at the helm. And Andre Marion believes that what once worked for the company is also the surest route to its future success. "Success lies in the ability to take chances," says Marion, who returned to hands-on management o
Industry Becomes More Hospitable To The Scientist As New Mother
Ricki Lewis | Jan 8, 1995 | 6 min read
The challenge of successfully combining the demands of family and career may be easing for women scientists in industry. With increasing numbers of women opting to work in private- sector research laboratories--and in the wake of the Family and Medical Leave Act of 1993--many firms have revamped maternity-leave policies to better accommodate new parenthood and the transition back to work. The recently enacted federal law ensures workers in companies with 50 or more employees 12 weeks of unpaid,
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo

Run a Search

ADVERTISEMENT